Published in Women's Health Weekly, March 11th, 1996
"I think it's a major step forward" toward developing a new therapy, said Dawn Willis, director of research communication at the American Cancer Society.
The experimental treatment involved injections of the gene BRCA1. Inherited susceptibility to breast and ovarian cancers is caused by a defective BRCA1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.